Short-term inhalation of cadmium oxide nanoparticles alters pulmonary dynamics associated with lung injury, inflammation, and repair in a mouse model

Inhalation Toxicology

Volumn 26, Issue 1, 2014, Pages 48-58

  Blum, Jason L ^a   Rosenblum, Lauren K ^a   Grunig, Gabriele ^a   Beasley, Mary Beth ^b   Xiong, Judy Q ^a   Zelikoff, Judith T ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cadmium oxide nanoparticles; Inflammation; Inhalation; Metal oxide; Phagocytosis; Pulmonary injury

Indexed keywords

CADMIUM OXIDE; GAMMA INTERFERON; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; LACTATE DEHYDROGENASE; NANOPARTICLE; PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY REMODELING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNE RESPONSE; INHALATION; LEUKOCYTE COUNT; LUNG ALVEOLUS CELL; LUNG INJURY; LUNG LAVAGE; LUNG WEIGHT; LYMPHOCYTE COUNT; MALE; MOUSE; MOUSE MODEL; NONHUMAN; OCCUPATIONAL EXPOSURE; PHAGOCYTE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADMINISTRATION, INHALATION; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CADMIUM COMPOUNDS; CYTOKINES; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; L-LACTATE DEHYDROGENASE; LEUKOCYTE COUNT; LUNG; LUNG INJURY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METAL NANOPARTICLES; MICE; OXIDES; PHAGOCYTOSIS; PNEUMONIA;

EID: 84892771523     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2013.851746     Document Type: Article

References (53)

1. Aiso S, Yamazaki K, Umeda Y, et al. (2010). Pulmonary toxicity of intratracheally instilled multiwall carbon nanotubes in male Fischer 344 rats. Ind Health 48: 783-95.
2. Alessandrini F, Ziesenis A, Takenaka S, et al. (2003). Effects of inhaled CdO particles on the sphingolipid synthesis of rat lungs. Inhal Toxicol 15: 343-56. (Pubitemid 36458884)
3. Aman J, van der Heijden M, van Lingen A, et al. (2011). Plasma protein levels are markers of pulmonary vascular permeability and degree of lung injury in critically ill patients with or at risk for acute lung injury/ acute respiratory distress syndrome. Crit Care Med 39: 89-97.
4. Barazzone C, Horowitz S, Donati YR, et al. (1998). Oxygen toxicity in mouse lung: pathways to cell death. Am J Respir Cell Mol Biol 19: 573-81. (Pubitemid 128354238)
5. Blum JL, Xiong JQ, Hoffman C, Zelikoff JT. (2012). Cadmium associated with inhaled cadmium oxide nanoparticles impacts fetal and neonatal development and growth. Toxicol Sci 126: 478-6.
6. Bolognin M, Kirschvink N, Leemans J, et al. (2009). Characterization of the acute and reversible airway inflammation induced by cadmium chloride inhalation in healthy dogs and evaluation of the effects of salbutamol and prednisolone. Vet J 179: 443-50.
7. Braun A, Ernst H, Homann HG, Rittinghausen S. (2004). Respiratory tract. In: Hedrich H. (ed.) The laboratory mouse, 2nd ed. New York: Elsevier Academic Press, 225-43.
8. Buckley BJ, Bassett DJ. (1987). Pulmonary cadmium oxide toxicity in the rat. J Toxicol Environ Health 21: 233-50. (Pubitemid 17067370)
9. Card JW, Zeldin DC, Bonner JC, Nestmann ER. (2008). Pulmonary applications and toxicity of engineered nanoparticles. Am J Physiol Lung Cell Mol Physiol 295: 400-11.
10. Cassee FR, Muijser H, Duistermaat E, et al. (2002). Particle sizedependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model. Arch Toxicol 76: 277-86. (Pubitemid 34639523)
11. Chan P, Yuen T, Ruf F, et al. (2005). Method for multiplex cellular detection of mRNAs using quantum dot fluorescent in situ hybridization. Nucl Acids Res 33:e161. doi: 10.1093/nar/gni162. (Pubitemid 41742637)
12. Coulter KR, Wewers MD, Lowe MP, Knoell DL. (1999). Extracellular regulation of interleukin (IL)-1beta through lung epithelial cells and defective IL-1 type II receptor expression. Am J Respir Cell Mol Biol 20: 964-75. (Pubitemid 129540854)
13. Drent M, Cobben NA, Henderson RF, et al. (1996). Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J 9: 1736-42. (Pubitemid 26271162)
14. EPA. (2000). Cadmium compounds. Technology Transfer Network. Available from: http://www.epa.gov/ttn/atw/hlthef/cadmium.html [Last accessed: 16 Aug 2013].
15. Ferin J, Oberdorster G. (1992). Translocation of particles from pulmonary alveoli into the interstitium. J Aerosol Med 5: 179-87.
16. Gang S, Dutt-Sharma G, Sengupta M. (2009). Intracellular survival of Staphylococcus aureus due to alteration of cellular activity in cadmium intoxicated Swiss albino mice. Assam Univ J Sci Tech 4: 61-5.
17. Garg P, Vijay-Kumar M, Wang L, et al. (2009). Matrix metalloproteinase- 9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis. Am J Physiol Gastrointest Liv Physiol 296:G175-84.
18. Gopcevic K, Rovcanin B, Kekic D, Radenkovic S. (2011). Matrix metalloproteinases and membrane damage markers in sera of patients with acute myocardial infarction. Mol Cell Biochem 350: 163-8.
19. Grassian VH. (2008). When size really matters: size-dependent properties and surface chemistry of metal and metal oxide nanoparticles in gas and liquid phase environments. J Phys Chem C 112: 18303-13.
20. Greenspan BJ, Morrow PE. (1984). The effects of in vitro and aerosol exposures to cadmium on phagocytosis by rat pulmonary macrophages. Fundam Appl Toxicol 4: 48-57. (Pubitemid 14195123)
21. Holden H. (1980). Cadmium and pulmonary emphysema. Lancet 315: 1137. (Pubitemid 10100383)
22. Kang H, Liu H, Zhang X, et al. (2011). Photoresponsive DNA-crosslinked hydrogels for controllable release and cancer therapy. Langmuir 27: 399-408.
23. Kleiner DE, Stetler-Stevenson WG. (1994). Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 218: 325-9. (Pubitemid 24141631)
24. Krzystyniak K, Fournier M, Trottier B, et al. (1987). Immunosuppression in mice after inhalation of cadmium aerosol. Toxicol Lett 38: 1-12. (Pubitemid 17147430)
25. Kuhlbusch TAJ, Asback C, Fissan H, et al. (2011). Nanoparticle exposure at nanotechnology workplaces: a review. Part Fibre Toxicol 8: 1-18.
26. Kundu S, Sengupta S, Chatterjee S, et al. (2009). Cadmium induces lung inflammation independent of lung cell proliferation: a molecular approach. J Inflamm (Lond) 6: 19-34.
27. Kunisawa J, Fukuyama S, Kiyono H. (2005). Mucosa-associated lymphoid tissues in the aerodigestive tract: their shared and divergent traits and their importance to the orchestration of the mucosal immune system. Curr Mol Med 5: 557-72. (Pubitemid 41236556)
28. Lag M, Rodionov D, Ovrevik J, et al. (2010). Cadmium-induced inflammatory responses in cells relevant for lung toxicity: expression and release of cytokines in fibroblasts, epithelial cells and macrophages. Toxicol Lett 193: 252-60.
29. Levine SJ, Wu T, Shelhamer JH. (1997). Extracellular release of the type I intracellular IL-1 receptor antagonist from human airway epithelial cells: differential effects of IL-4, IL-13, IFN-gamma, and corticosteroids. J Immunol 158: 5949-57. (Pubitemid 127484004)
30. Lohi J, Lehti K, Westermarck J, et al. (1996). Regulation of membranetype matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem 239: 239-47. (Pubitemid 26246526)
31. Lu Z, Qiao Y, Zheng XT, et al. (2010). Effect of particle shape on phagocytosis of CdTe quantum dot-cystine composites. Med Chem Commun 1: 84-6.
32. Luparello C, Sirchia R, Longo A. (2011). Cadmium as a transcriptional modulator in human cells. Crit Rev Toxicol 41: 75-82.
33. Marquis B, Love S, Braun K, Haynes C. (2009). Analytical methods to assess nanoparticle toxicity. Analyst 134: 425-39.
34. Moyron-Quiroz JE, Rangel-Moreno J, Kusser K, et al. (2004). Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 10: 927-34. (Pubitemid 39273733)
35. Mukhopadhyay S, Hoidal JR, Mukherjee TK. (2006). Role of TNFalpha in pulmonary pathophysiology. Respir Res 7: 125-34.
36. Oberdorster G. (1986). Airborne cadmium and carcinogenesis of the respiratory tract. Scand J Work Environ Health 12: 523-37. (Pubitemid 17218449)
37. OSHA. (2004). Cadmium. Washington, DC: U.S. Department of Labor Occupational Safety and Health Administration OSHA 3136-06R. Available from: http://www.osha.gov/Publications/osha3136.pdf. [Last accessed: 16 Aug 2013].
38. OSHA. (2012). Available from: http://www.osha.gov/dts/chemicalsampling/ data/CH-223897.html. [Last accessed: 11 Sep 2013].
39. Papp A, Oszlánczi G, Horváth E, et al. (2012). Consequences of subacute intratracheal exposure of rats to cadmium oxide nanoparticles: electrophysiological and toxicological effects. Toxicol Ind Health 28: 933-41.
40. Revell PA. (2006). The biological effects of nanoparticles. Nanotech Percep 2: 283-98.
41. Roberts JR, Antonini JM, Porter DW, et al. (2013). Lung toxicity and biodistribution of Cd/Se-ZnS quantum dots with different surface functional groups after pulmonary exposure in rats. Part Fibre Toxicol 10:5. doi:10.1186/1743-8977-10-5.
42. Sarkar S, Yadav P, Bhatnagar D. (1998). Lipid peroxidative damage on cadmium exposure and alterations in antioxidant system in rat erythrocytes: a study with relation to time. Biometals. 11: 153-7. (Pubitemid 28140336)
43. Schreck R, Rieber P, Baeuerle PA. (1991). Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10: 2247-58. (Pubitemid 21905698)
44. Snider GL, Hayes JA, Korthy AL, Lewis GP. (1973). Centrilobular emphysema experimentally induced by cadmium chloride aerosol. Am Rev Respir Dis 108: 40-8.
45. Soccal PM, Gasche Y, Pache JC, et al. (2000). Matrix metalloproteinases correlate with alveolar-capillary permeability alteration in lung ischemia-reperfusion injury. Transplantation 70: 998-1005.
46. Srinivas A, Rao PJ, Selvam G, et al. (2011). Acute inhalation toxicity of cerium oxide nanoparticles in rats. Toxicol Lett 205: 105-15.
47. Stosic J, Mirkov I, Belij S, et al. (2010). Gender differences in pulmonary inflammation following systemic cadmium administration in rats. Biomed Environ Sci 23: 293-9.
48. Takenaka S, Karg E, KreylingWG, et al. (2004). Fate and toxic effects of inhaled ultrafine cadmium oxide particles in the rat lung. Inhal Toxicol 16: 83-92. (Pubitemid 38923904)
49. Takenaka S, Oldiges H, König H, et al. (1983). Carcinogenicity of cadmium chloride aerosols in W rats. J Natl Cancer Inst 70: 367-73. (Pubitemid 13164035)
50. van Broekhuizen P, van Veelen W, Streekstra WH, et al. (2012). Exposure limits for nanoparticles: report of an international workshop on nano reference values. Ann Occup Hyg 56: 515-24.
51. Waisberg M, Joseph P, Hale B, Beyersmann D. (2003). Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 192: 95-117. (Pubitemid 37311405)
52. Yamada M, Kubo H, Kobayashi S, et al. (2004). Interferon-gamma: a key contributor to hyperoxia-induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol 287:L1042-7. (Pubitemid 39391035)
53. Zhang W, Fievez L, Zhang F, et al. (2010). Effects of formoterol and ipratropium bromide on repeated cadmium inhalation-induced pulmonary inflammation and emphysema in rats. Eur J Pharmacol 647: 178-87.